Obesity
Conditions
Keywords
Obesity, meditation, chronic kidney disease
Brief summary
Obesity plays a causal role for kidney disease incidence and progression. Moderate weight loss reduces the high metabolic demands on the kidney and decreases proteinuria in both diabetic and non-diabetic nephropathies. However, maintaining behavioral changes for weight loss is very challenging, and common chronic kidney disease (CKD) co-morbidities such as decreased exercise capacity only compound this difficulty. Moreover, no weight loss medications have been adequately tested in adults with CKD and most are contraindicated in this population. Mindful meditation or mindfulness in addition to other relaxation techniques may help adults lose weight by interrupting learned behavior, curbing compulsive eating, and reducing stress and appetite. Although mindful meditation and other relaxation techniques have gained the attention of the mainstream media for obesity treatment, scientific data on its efficacy remain limited. Due to the short duration of this study, substantial weight loss in any participant is not expected. Instead, the primary purpose of this study is to examine the feasibility of a randomized controlled trial of mindful meditation relaxation techniques combined with standard care compared to standard care alone for the treatment of obesity among Veterans with CKD.
Interventions
BEHAVIORALRelaxation methods
Relaxation methods will include mindful meditation techniques for the intervention and listening to music for the control arm
Sponsors
Edward Hines Jr. VA Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 88 Years
Healthy volunteers
No
Inclusion criteria
* receive medical care at the Hines VA CKD clinics. * Presence of chronic kidney disease defined as an estimated glomerular filtration rate \< 60 ml/min/1.73 m2 BSA or a spot urine albumin/creatinine ratio ≥ 30 mg/g * BMI ≥ 35 kg/m2 or a waist circumference ≥ 102 (40 inches) and ≥ 88 cm (35 inches) in men and women, respectively.
Exclusion criteria
* Inability to give informed consent * inability to come to VA for two group sessions * inability to listen to an MP3 player using headphones
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| weight, waist circumference, measures of stress and mood and overall satisfaction | 8 nweeks |
Countries
United States
Outcome results
None listed